Clinical trial
Treating Nonalcoholic Steatohepatitis With Pioglitazone
NCT00062764 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00062764 |
|---|---|
| Title | Treating Nonalcoholic Steatohepatitis With Pioglitazone |
| Official title | Long-Term Treatment of Nonalcoholic Steatohepatitis With Pioglitazone |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis |
| Intervention type | Drug |
| Interventions | Actos (Pioglitazone) |
| Enrollment | 18 |
| Start date | Jun 1, 2003 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Jun 13, 2003 |
| Last update posted | Dec 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: